When people with panic disorder consume 400 mg of caffeine, their stress hormone levels — ACTH, cortisol, and DHEAS — rise significantly compared to when they take a placebo, showing that caffeine triggers a biological stress response even if it doesn’t cause panic.
Evidence from Studies
Supporting (1)
Community contributions welcome
Caffeine made people with panic disorder have higher stress hormones, even if they didn’t feel panicked—so caffeine wakes up the body’s stress system whether or not someone has a panic attack.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis could determine whether caffeine consistently activates the HPA-axis across PD populations and whether this effect is dose-dependent.
A systematic review and meta-analysis of all randomized, placebo-controlled caffeine challenge studies in adults with DSM-5 panic disorder, pooling standardized mean differences in ACTH, cortisol, and DHEAS changes across doses (200–750mg), with subgroup analyses by sex, medication status, and comorbid anxiety.
A larger RCT could quantify the magnitude of HPA-axis activation and determine whether it correlates with other physiological markers like heart rate or respiratory rate.
A double-blind, placebo-controlled, crossover RCT with 150+ adults with PD, receiving 200mg, 400mg, and 750mg caffeine and placebo on separate days, measuring ACTH, cortisol, DHEAS, heart rate variability, and respiratory rate at 15, 30, and 60 minutes post-ingestion.
A prospective cohort could determine whether individuals with PD who show strong HPA-axis responses to caffeine are more likely to develop chronic stress-related comorbidities.
A 5-year prospective cohort study following 250 adults with PD who undergo a 400mg caffeine challenge; those with high vs. low HPA-axis activation are tracked for development of depression, metabolic syndrome, or burnout, adjusting for lifestyle and medication.
A case-control study could compare HPA-axis reactivity in PD patients with and without comorbid depression to determine if hormone response patterns differ.
A case-control study comparing 50 PD patients with comorbid major depression (cases) to 50 without (controls), matched for age, sex, and caffeine intake, measuring baseline and post-400mg caffeine ACTH, cortisol, and DHEAS changes.
A cross-sectional study could estimate the prevalence of HPA-axis activation in PD patients based on self-reported caffeine use.
A cross-sectional study measuring plasma ACTH, cortisol, and DHEAS in 400 adults with PD recruited from clinics, correlating levels with self-reported daily caffeine intake (mg/day) and panic attack frequency.